FRASCA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 5.706
EU - Europa 3.327
AS - Asia 2.895
SA - Sud America 457
AF - Africa 413
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AN - Antartide 1
Totale 12.811
Nazione #
US - Stati Uniti d'America 5.490
SG - Singapore 1.507
RU - Federazione Russa 1.117
CN - Cina 914
IT - Italia 908
IE - Irlanda 450
BR - Brasile 399
UA - Ucraina 372
CI - Costa d'Avorio 313
CA - Canada 177
DE - Germania 170
VN - Vietnam 128
KR - Corea 106
IN - India 69
GB - Regno Unito 59
SE - Svezia 55
SN - Senegal 47
PL - Polonia 31
FR - Francia 28
FI - Finlandia 27
MX - Messico 26
TR - Turchia 26
AR - Argentina 25
IR - Iran 24
NL - Olanda 22
CH - Svizzera 20
JP - Giappone 20
UZ - Uzbekistan 17
CZ - Repubblica Ceca 15
ZA - Sudafrica 15
BD - Bangladesh 14
BJ - Benin 14
ES - Italia 14
ID - Indonesia 14
EC - Ecuador 12
BE - Belgio 9
AZ - Azerbaigian 7
GR - Grecia 7
IQ - Iraq 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
CO - Colombia 6
PY - Paraguay 6
SA - Arabia Saudita 6
EU - Europa 5
KE - Kenya 5
MA - Marocco 5
VE - Venezuela 5
BG - Bulgaria 4
HK - Hong Kong 4
LT - Lituania 4
NG - Nigeria 4
PK - Pakistan 4
RO - Romania 4
AT - Austria 3
DO - Repubblica Dominicana 3
IL - Israele 3
LB - Libano 3
LU - Lussemburgo 3
TN - Tunisia 3
BH - Bahrain 2
CL - Cile 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PE - Perù 2
PS - Palestinian Territory 2
TW - Taiwan 2
AL - Albania 1
AQ - Antartide 1
BB - Barbados 1
BN - Brunei Darussalam 1
DK - Danimarca 1
GA - Gabon 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
PH - Filippine 1
PR - Porto Rico 1
RS - Serbia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.811
Città #
Dallas 886
Singapore 881
Santa Clara 735
Chandler 491
Moscow 485
Dublin 449
Chicago 404
Jacksonville 391
Abidjan 313
Houston 245
Ashburn 241
Hefei 219
Boardman 203
Catania 197
Civitanova Marche 164
Los Angeles 143
Beijing 130
Quintano 129
Nanjing 127
Cambridge 122
Lawrence 121
Andover 119
Toronto 115
Seoul 105
Grafing 79
Wilmington 71
San Mateo 62
Des Moines 59
Buffalo 49
Dakar 47
Ho Chi Minh City 46
Nanchang 44
New York 43
Bremen 39
São Paulo 39
Palermo 36
Hebei 34
Jiaxing 31
Munich 30
Saint Petersburg 29
Shenyang 29
Ottawa 28
Council Bluffs 27
The Dalles 27
Bari 26
Hanoi 26
Columbus 25
Kochi 24
Changsha 23
Warsaw 23
Tianjin 22
San Francisco 20
Tokyo 20
Milan 17
Ardabil 16
Atlanta 16
Lappeenranta 16
Montreal 16
Stockholm 16
Amsterdam 15
Brooklyn 15
Rio de Janeiro 15
San Jose 15
Cotonou 14
Brno 13
Manchester 13
Orem 12
Pozzallo 12
Rome 12
Augusta 11
Denver 11
Dong Ket 11
Phoenix 11
Pune 11
Washington 11
Chennai 10
Johannesburg 10
Mascalucia 10
Redondo Beach 10
Seattle 10
Ankara 9
Brussels 9
Curitiba 9
Leawood 9
Paternò 9
Belpasso 8
Brasília 8
Jinan 8
London 8
Mexico City 8
Vancouver 8
Campinas 7
Falls Church 7
Guangzhou 7
Mumbai 7
Redwood City 7
Turku 7
Belo Horizonte 6
Jakarta 6
Naples 6
Totale 8.975
Nome #
Peroxisomal proliferator-activated receptor-γ agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells 341
Correction to: Analysis of common methodological flaws in the highest cited e-cigarette epidemiology research (Internal and Emergency Medicine, (2022), 17, 3, (887-909), 10.1007/s11739-022-02967-1) 185
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 181
17beta-estradiol up-regulates the insulin-like growth factor receptor through a nongenotropic pathway in prostate cancer cells 170
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 161
c-Abl and insulin receptor signalling 159
Different FT3/TSH correlation in acquired and congenital hypothyroid patients reveals a different hypothalamic set-point 142
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 138
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 137
Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid 137
BRAF(V600E) mutation and the biology of papillary thyroid cancer 131
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 131
Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism 129
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 128
Curcumin, hormesis and the nervous system 128
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 126
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells 124
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells 124
Challenges in the treatment of parathyroid carcinoma: a case report 124
Thyrospheres From Normal or Malignant Thyroid Tissue Have Different Biological, Functional, and Genetic Features 119
Early Massive Fibrosis of a Single Extraocular Muscle Causing Severe Unilateral Euthyroid Graves' Ophthalmopathy in a Patient with Hypercholesterolemia Who Smokes 117
Levothyroxine therapy, calculated deiodinases activity and basal metabolic rate in obese or nonobese patients after total thyroidectomy for differentiated thyroid cancer, results of a retrospective observational study 116
Early detection of suspicious lymph nodes in differentiated thyroid cancer 116
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression 116
ROLE OF BRAF(V600) MUTATION IN THE RESISTANCE TO GEFITINIB OF THYROID CANCER CELLS 114
Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management 110
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes 110
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 110
Interleukin-4 stimulates papillary thyroid cancer cell survival: Implications in patients with thyroid cancer and concomitant Graves' disease 108
BRAF T1799A Mutation in Thyroid Cancer Predicts Progressive disease 107
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 107
DeltaNp73alfa favors thyroid tumor progression by PTEN tumor suppressor downregulation 106
Sex steroids upregulate the IGF-1R in prostate cancer cells through a nongenotropic pathway 104
Insulin receptor isoforms in physiology and disease: An updated view 104
Surveillance of patients with differentiated thyroid cancer and indeterminate response: a longitudinal study on basal thyroglobulin trend 103
Worldwide increasing incidence of thyroid cancer:update on epidemiology and risk factors 102
Updates on the management of advanced, metastatic, and radioiodine refractory differentiated thyroid cancer 101
Evidence That Baseline Levels of Low-Density Lipoproteins Cholesterol Affect the Clinical Response of Graves' Ophthalmopathy to Parenteral Corticosteroids 100
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 99
DeltaNp73alfa increases Akt phosphorylation in thyroid cancer cells: role of PTEN tumor suppressor 95
TAp73α increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation 95
Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis 93
Effect of gluten-free diet on autoimmune thyroiditis progression in patients with no symptoms or histology of celiac disease: a meta-analysis 92
p73 tumor-suppressor activity is impaired in human thyroid cancer 92
Medullary thyroid cancer in MEN2 pediatric/adolescent carriers of RET mutation: genotype/phenotype correlation and outcome in a retrospective series of 23 patients 91
Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review 90
Consider or not consider: the unsolved question on the use of radioactive iodine for differentiated thyroid cancer with low to intermediate risk of recurrence 89
Exclusion of c-Abl from the Nucleus Restrains the p73 Tumor Suppression Function 89
Role of selenium and myo-inositol supplementation on autoimmune thyroiditis progression 89
p53 family proteins in thyroid cancer 88
Reactivation of p53 mutants by p53 reactivation and induction of massive apoptosis in thyroid cancer cells 88
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 87
Effetto del trattamento epigenetico combinato di acido valproico e 5-Azacitidina in un modello di carcinomi della Tiroide poco differenziati 87
Papillary thyroid cancer incidence in the volcanic area of Sicily 86
Isolation and characteriziation of cancer thyrospheres 86
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 86
The p53-homologue p63 may promote thyroid cancer progression 85
Cytological diagnosis difficulties in hyalinizing trabecular adenoma of the thyroid 85
The isoform A of the insulin receptor as a regulator of the IGF system 84
Clinical Assessment of Altered Eating Behaviors in People with Obesity Using the EBA-O Questionnaire 84
Il BRAF (V600E) è responsabile della resistenza delle cellule di carcinoma tiroideo al gefinitib. 83
Impact of post-operative radioiodine remnant abalation in differentiated thyroid cancer according to risk categories. 83
INVOLVEMENT OF THE P53 HOMOLOGOUS P73 IN THYROID CANCER PROGRESSION 83
The possible role of cancer stem cells in the resistance to kinase inhibitors of advanced thyroid cancer 83
Seasonal Variations in TSH Serum Levels in Athyreotic Patients under L-Thyroxine Replacement Monotherapy. 82
Selenium exerts protective effects against oxidative stress and cell damage in human thyrocytes and fibroblasts 82
Endocrinopatie e anemie / anemie ed endocrinopatie: una si(pali)ndrome spesso misconosciuta 81
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 81
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 81
Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity 81
Thyroid Cancer and Circadian Clock Disruption 81
Clinical management of indeterminate thyroid nodules needs to be revisited. New evidence for a personalized approach to the problem 80
Nuove strategie di indagine delle linfoadenopatie nel carcinoma tiroideo 80
Associazione tra la sindrome metabolica e le caratteristiche clinico-patologiche del carcinoma papillifero tiroideo 80
The SGLT-1/SGLT-2 dual inhibitor canagliflozin has positive effects on glucose trends, targets and variability in late dumping syndrome following gastrectomy: A case report 79
Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor 79
Therapeutic efficacy and patient compliance of levothyroxine liquid and softgel formulations taken with meals: a systematic review 78
Insulin and hybrid insulin/IGF receptors are major regulators of breast cancer cells 78
EXOME WIDE ANALYSIS IN 5 PAPILLARY THYROID CARCINOMAS 78
Le cellule staminali tiroidee, isolate da gozzi di soggetti adulti, crescono in aggregati sferici in risposta a stimolazione con fattori di crescita e necessitano del TSH per differenziare in Tireociti maturi 78
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 78
The role of insulin receptor isoform a (IR-A) in cancer 78
Interleukin-1 blocks insulin and insulin-like growth factor-stimulated growth in MCF-7 human breast cancer cells by inhibiting receptor tyrosine kinase activity 77
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 77
HMGA1 inhibits the function of p53 family members in thyroid cancer cells 77
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 77
TAp63alfa antagonizes p53 oncosuppressor function in thyroid cancer cells 76
Thyroid cancer cell resistance to gefinitib depends on the constitutive oncogenic activation of the ERK pahway 76
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years 76
Obesity, insulin-resistance and cancer 75
Fine-needle aspiration molecular analysis for the diagnosis of papillary thyroid carcinoma through BRAF V600E mutation and RET/PTC rearrangement 75
Pre-Operative Calcitonin and CEA Values May Predict the Extent of Metastases to the Lateral Neck Lymph Nodes in Patients with Medullary Thyroid Cancer 74
In thyroid cancer cell lines expression of periostin gene is controlled by p73 and is not related to epigenetic marks of active transcription 74
Thyrospheres an in vitro model for human thyroid carcinogenesis 74
The tall cell variant of papillary thyroid carcinoma: clinical and pathological features and outcomes. 74
The Insulin Receptor in Breast Cancer 73
Tap73alfa Increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of mdm2-mediated degradation 73
Expression of neurotrophins, GDNF and their receptors in rat thyroid tissue 73
IGF and insulin receptor signaling in breast cancer 73
Diabetes and cancer 73
Totale 10.040
Categoria #
all - tutte 42.361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.361


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021413 0 0 0 0 0 22 87 14 135 4 127 24
2021/2022879 107 128 6 11 127 9 134 34 81 3 27 212
2022/20231.700 129 46 31 316 150 278 2 264 388 21 46 29
2023/2024829 40 128 33 58 41 153 41 63 6 20 111 135
2024/20253.135 40 615 154 266 629 336 60 93 190 273 237 242
2025/20264.581 403 393 1.130 481 1.019 1.155 0 0 0 0 0 0
Totale 13.043